SCHEMBL28225243

SCHEMBL28225243

[CH2]C(N)N1CCCCC1C(=O)O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACE P12821 7/20 0.35
REN P00797 3/20 0.35
KDM4E B2RXH2 1/20 0.35
F2 P00734 1/20 0.35
LMNA P02545 1/20 0.35
LTA4H P09960 1/20 0.35
MAPT P10636 1/20 0.35
PEPD P12955 1/20 0.35
ALOX15 P16050 1/20 0.35
PTGS1 P23219 1/20 0.35
HTR2A P28223 1/20 0.35
PTGS2 P35354 1/20 0.35
HRH1 P35367 1/20 0.35
THPO P40225 1/20 0.35
PMP22 Q01453 1/20 0.35
HSD17B10 Q99714 1/20 0.35
ACE2 Q9BYF1 1/20 0.35
RAB9A P51151 1/20 0.34
ALDH1A1 P00352 1/20 0.34
HTT P42858 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28225249 0.83 ACE (0.36) ACERENKDM4EF2LMNA
SCHEMBL28299734 0.81 ACE (0.41) ACERENKDM4EF2LMNA
SCHEMBL584218 0.77 ACE (0.44) ACERENKDM4EF2LMNA
SCHEMBL584217 0.77 ACE (0.44) ACERENKDM4EF2LMNA
SCHEMBL58639 0.77 ACE (0.44) ACERENKDM4EF2LMNA
SCHEMBL6516944 0.76 ACE (0.46) ACERENKDM4EF2LMNA
SCHEMBL5017112 0.76 ACE (0.46) ACERENKDM4EF2LMNA
SCHEMBL59537 0.74 ACE (0.41) ACERENKDM4EF2LMNA
SCHEMBL22966485 0.74 ACE (0.41) ACERENKDM4EF2LMNA
SCHEMBL14211021 0.74 ACE (0.41) ACERENKDM4EF2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108239089-A A kind of synthetic method of AVM hereinafter Batan sodium 浙江医药股份有限公司新昌制药厂 2018-07-03 CN claimed
CN-108239089-A A kind of synthetic method of AVM hereinafter Batan sodium 浙江医药股份有限公司新昌制药厂 2018-07-03 CN disclosed